Prescription abandonment linked to cost and coverage hurdles
Rising out-of-pocket costs and prior authorization delays are associated with more patients abandoning prescriptions. The article describes medication nonadherence as a pricing and access problem rather than a failure of willpower. It suggests showing cost and coverage details at the point of prescribing to help patients begin and stay on therapy.
Patients who face higher personal spending or delays while coverage is reviewed appear more likely to leave prescriptions unfilled. The story frames this pattern as a consequence of pricing and access barriers, not as a personal shortcoming.
It also points to a practical response: giving patients and prescribers clear information about costs and coverage when a medicine is ordered. Such transparency may help people start treatment and continue it as prescribed.
The story could affect patients, clinicians, health systems, and coverage organizations by highlighting cost and coverage barriers at the point of prescribing. Clearer information may help some patients begin and continue treatment, potentially improving continuity of care. It may also encourage health systems to view nonadherence as an access problem, though the actual impact would depend on how such information is used in practice.